Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasmatic Level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictive Marker of Acute Kidney Failure in Patients With Preoperative Chronic Kidney Failure Undergoing Cardiac Surgery.

NCT01227122 is registered in ClinicalTrials.gov with Hopital Jean Minjoz as lead sponsor.

NCT NCT01227122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasmatic Level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictive Marker of Acute Kidney Failure in Patients With Preoperative Chronic Kidney Failure Undergoing Cardiac Surgery.
Lead sponsor
Hopital Jean Minjoz
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
September 30, 2013
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgical procedures, postoperative kidney failure, acute, preoperative kidney failure, chronic